secwatch.observer — SEC 8-K summary
======================================

Issuer:     CAPRICOR THERAPEUTICS, INC. (CAPR)
CIK:        0001133869
Form:       8-K
Filed at:   2023-06-13T23:59:59+00:00
Accession:  0001558370-23-011046
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Capricor Therapeutics shareholders elect all seven director nominees and approve all proposals at 2023 Annual Meeting
--------------------------------------------------------------------------------

- Seven director nominees elected: Litvack, Marbán, Musket, Dunbar, Manzo, Collier, Es Sabar (FOR votes 4.9M-5.9M; ~9.4M broker non-votes).
- Rose, Snyder & Jacobs LLP ratified as auditor for FY2023: 14.6M FOR, 0.4M AGAINST, 1.3M abstain.
- Non-binding advisory vote on named executive officer compensation approved: 4.3M FOR, 2.4M AGAINST, 0.2M abstain.
- Amendment to Certificate of Incorporation for officer exculpation approved: 5.0M FOR, 1.8M AGAINST, 0.1M abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1133869/000155837023011046/0001558370-23-011046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1133869/000155837023011046/capr-20230612x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-011046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer